[ÇóÖú] Çë½Ì¹ØÓÚרÀû·½ÃæµÄһЩ·­ÒëÎÊÌ⣬¼±£¡

×î½üÓм¸Æª¹ØÓÚרÀû·½ÃæµÄһЩ¶«Î÷ÐèÒª·­Ò룬ÓÉÓÚСµÜ֮ǰûŪ¹ýÕâ¸ö£¬ÏñϱߴøÏ»®ÏßµÄÕâЩӢÎÄËõд¾Í²»ÖªµÀ¸ÃÔõôÒëÁË£¬»¹Íû¸ßÊÖÖ¸µãÒ»¶þ£¬°Ýл£¡£¨Àï±ß¾ßÌåÄÚÈݲ»Ó÷­Ò룬ÎÒ×Ô¼º¾Í¿ÉÒÔÁË£¬Ö÷ÒªÊÇÒ»ÆðÌù³öÀ´·½±ã¿´¶® £© AN - 2005-081429 [09]   AP - WO2004JP08924 20040618; DE200460025935 20040618; EP20040746393   20040618; [PCT Application] WO2004JP08924 20040618; JP20050507289   20040618; US20060561298 20060607; [Based on EP1640380 A 00000000];   [Based on WO2004113366 A 00000000]    PR - JP20030177298 20030620    TI - New cyclic tetrapeptide is histone deacetylase inhibitor, useful for   treating e.g. cancer, autoimmune disease or skin disease   IW - NEW CYCLIC HISTONE INHIBIT USEFUL TREAT CANCER DISEASE SKIN   PA - (RICR ) DOKURITSU GYOSEI HOJIN RIKAGAKU KENKYUSH   - (RIKE ) RIKEN KK   - (NISH-I) NISHINO N   - (YOSH-I) YOSHIDA M    PN - WO2004113366 A1 20041229 DW200509   EP1640380 A1 20060329 DW200623   US2007185071 A1 20070809 DW200754   JP2005507289T2 T2 20070920 DW200764   US7662778 B2 20100216 DW201013   EP1640380 B1 20100310 DW201018   DE602004025935E E 20100422 DW201028   JP4550738B2 B2 20100922 DW201062 ICAI- A61K31/555; A61K38/00; A61P17/00; A61P25/28; A61P31/00; A61P35/00;   A61P35/04; A61P37/00; A61P43/00; A61P9/00; C07K5/12; C12N9/99   ICCI- A61K31/555; A61K38/00; A61P17/00; A61P25/00; A61P31/00; A61P35/00;   A61P37/00; A61P43/00; A61P9/00; C07K5/00; C12N9/99    AB - NOVELTY :    A cyclic tetrapeptide compound (1) is new.   - DETAILED DESCRIPTION :    A cyclic tetrapeptide compound of formula (1) is new.

»Ø¸´´ËÂ¥